16•12

Curated by Signal

Provider of a diagnostic device to evaluate the patient's hemorrhagic and thrombotic potential

Overview

Provider of a diagnostic device to evaluate the patient's hemorrhagic and thrombotic potential. The company offer a diagnostic platform called Smart Clot, which allows for the evaluation of platelet adhesion, aggregation, and fibrin formation. It aims to improve patient outcomes in cardiovascular diseases such as heart attacks and strokes.

Key facts

Founded: 2005
Headquarters: Pordenone, Italy
Stage: Sign up to view
Industry: Health Technology

Business model

1 product or service: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Fedele Assistance
Online teleconsultation tool for elderly
Health TechnologyTurin, Italy
Residenze Sanitarie
Online platform offering general health & wellness information to users
Health TechnologyCisterna di Latina, Italy
GMI
A range of radiology systems and accessories
Health TechnologyMontefredane, Italy

About 16•12

What does 16•12 do?

Provider of a diagnostic device to evaluate the patient's hemorrhagic and thrombotic potential.

Where is 16•12 headquartered?

16•12 is headquartered in Pordenone, Italy.

When was 16•12 founded?

16•12 was founded in 2005.

Which sector is 16•12 in?

16•12 operates in Health Technology.

Who are 16•12's competitors?

Companies similar to 16•12 include Fedele Assistance, Residenze Sanitarie, and GMI.